PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity

Guang Lei; Amber Horbath; Zhuang Li; Boyi Gan

doi:10.1002/cac2.12319

PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity

Guang Lei, Amber Horbath, Zhuang Li, Boyi Gan

Experimental Radiation Oncology

Research output: Contribution to journal › Editorial › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	583-586
Number of pages	4
Journal	Cancer Communications
Volume	42
Issue number	7
DOIs	https://doi.org/10.1002/cac2.12319
State	Published - Jul 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cac2.12319

Cite this

@article{d97088af3f2e4c53b1a20cd7968dc30c,

title = "PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity",

author = "Guang Lei and Amber Horbath and Zhuang Li and Boyi Gan",

note = "Funding Information: Research in the authors{\textquoteright} lab has been supported by The University of Texas MD Anderson Cancer Center, National Institutes of Health grants R01CA181196, R01CA244144, and R01CA247992, and Cancer Prevention & Research Institute of Texas grant RP220258 (to Boyi Gan), and by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute (to The University of Texas MD Anderson Cancer Center). ",

year = "2022",

month = jul,

doi = "10.1002/cac2.12319",

language = "English (US)",

volume = "42",

pages = "583--586",

journal = "Cancer Communications",

issn = "1000-467X",

publisher = "BioMed Central Ltd.",

number = "7",

}

TY - JOUR

T1 - PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity

AU - Lei, Guang

AU - Horbath, Amber

AU - Li, Zhuang

AU - Gan, Boyi

N1 - Funding Information: Research in the authors’ lab has been supported by The University of Texas MD Anderson Cancer Center, National Institutes of Health grants R01CA181196, R01CA244144, and R01CA247992, and Cancer Prevention & Research Institute of Texas grant RP220258 (to Boyi Gan), and by Cancer Center Support (Core) Grant P30 CA016672 from the National Cancer Institute (to The University of Texas MD Anderson Cancer Center).

PY - 2022/7

Y1 - 2022/7

UR - http://www.scopus.com/inward/record.url?scp=85131370193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131370193&partnerID=8YFLogxK

U2 - 10.1002/cac2.12319

DO - 10.1002/cac2.12319

M3 - Editorial

C2 - 35674490

AN - SCOPUS:85131370193

SN - 1000-467X

VL - 42

SP - 583

EP - 586

JO - Cancer Communications

JF - Cancer Communications

IS - 7

ER -

PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this